Tag: MDGS

Options Ideas, Fresh News on MDGS & More

Designer Brands, Inc. DBI – Options Update:

Last Tuesday morning, we signaled interest in tracking some longer-term options in the DBI chain, and began to monitor the DBI 10/15 $10-15 Calls.

It’s been a good week, with some respectable gains coming to those contracts so far. We still have more than two weeks remaining before their expiration, so we’ll be interested to see if they can deliver further results in the days ahead.

Here are the total possible gains on those targets to this point: 

DBI 10/15 $10-15 Calls
$10: 3.68-5.40 (+47%)
$12.50: 1.53-3.00 (+96%)
$15: .33-1.05 (+218%)
_____

Fresh Options Ideas: 
THO 10/15 $115-120 Calls
UNFI 10/15 $35-40 Calls

Medigus Ltd. (NASDAQ: MDGS) – Fresh News Alert:

We’ve also got another news alert this morning on MDGS, which we’ve been following for a month now. Our initial report on the company was on August 23rd, and you can find it here at this link.

Jeff Brands, of which Medigus is a majority stakeholder, is expanding its scope by way of a collaboration agreement with an established company. We’ve been talking about this company’s drive and focus on developing its interests at a rapid pace, and we have not been disappointed on that front.

OMER, Israel, Sept. 28, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Jeff Brands Ltd. (50.03%), a fast-growing consumer products goods (CPG) company, operating primarily on Amazon.com, will expand its business into e-commerce logistics warehouses. Jeff Brands signed a non-binding collaboration agreement with iFulfillYou LLC, a U.S.-based warehousing logistics services company under which the parties intend to collaborate for the establishment of logistics warehouses in the U.S. through a newly created company. (>>View Full PR)

Extended Watchlist:
ATIP, CYBL, TGGI, ILUS, TONR, CCAJ, FCGD, VBHI, SNOA, DBGI, ZIVO, ALF, PLAG

MDGS News Alert & More

Medigus Ltd. MDGS – News Alert:

Before we get into our routine Monday morning business, we’ve noticed a fresh PR hitting the wires on MDGS pertaining to not only the promising results from the first half of 2021, but a number of other key highlights.

We’ve been tracking MDGS for roughly a month now. You can check out our initial report on the company to familiarize yourself with the basics, and provide a little context to the facts and figures contained in today’s freshly released PR:

Medigus Ltd. Announces Record High Financial Results
Revenues for 1H 2021 increased by ~3,178% with first ever net profit of ~$8M

OMER, Israel, Sept. 20, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today its financial results for the first six months ended June 30, 2021

  • Revenues for the six-month period ended June 30, 2021, reached a record high, and totaled $2,393,000, an increase of $2,320,000 compared to $73,000 in the six-month period ended June 30, 2020
  • Net income for the period reached a record of $7,927,000 compared to a net loss of $3,599,000 in the six-month period ended June 30, 2020
  • Shareholders’ equity totaled $53,904,000 as of June 30, 2021
  • Cash and cash equivalents totaled $29,642,000 as of June 30, 2021

(>>View Full PR including figures and CEO commentary)

Options Reviews:

Our sole successful idea from Friday morning came in the LCID Weekly $21.50-22.50 Calls, which registered multibag intraday moves despite a poor day for the markets overall.

LCID Weekly $21.50-22.50 Calls
$21.50: .62-2.10 (+239%)
$22: .28-1.52 (+443%)
$22.50: .12-1.09 (+808%)

We also have some final figures on the SLQT Calls we tracked for weeks, which continuously registered new highs through essentially the entire period we were observing. They expired on Friday and turned in the following winning card:

SLQT 09/17 $7.50-10 Calls
$7.50: 1.80-7.34 (+308%)
$10: .40-5.04 (+1160%)

Extended Watchlist:
ILUS, CYBL, CYDY, AXTG, TGGI, NOUV, APYP, JPEX, 

Huge Gainers, Fresh Ideas & More

Options Reviews:

More options updates are on the menu for this morning, with a recap of yesterday’s winners, as well as an update on one of our current running ideas.

From yesterday morning’s premarket report, we have the AMBA Weekly $112-115 Calls and the PLAN 09/17 $65-75 Calls, as well as some new highs in the SLQT 09/17 $7.50-10 Calls which we signaled on Tuesday morning.

AMBA Weekly $112-115 Calls
$112: 7.30-19.96 (+173%)
$113: 7.60-19.00 (+150%)
$115: 3.00-17.60 (+487%)
_____

PLAN 09/17 $65-75 Calls
$65: 3.01-4.66 (+55%)
$70: .92-1.85 (+101%)
$75: .25-.50 (+100%)
_____

SLQT 09/17 $7.50-10 Calls
$7.50: 1.80-3.47 (+93%)
$10: .40-1.25 (+212%)

Fresh Options Ideas:
CHPT Weekly $24-25 Calls
NTNX Weekly $37.50-40 Calls
SIG Weekly $80-90 Calls
CHWY Weekly $83-79 Puts

Medigus Ltd. MDGS – News Alert:

Another fresh PR from MDGS this morning, alluding to a new patent filing pertaining to Polyrizon’s cutting edge infection-resisting hydrogel technology. We’ve been tracking developments in MDGS’ interests, and Polyrizon has been one of the most active.

OMER, Israel, Sept. 02, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, has submitted an additional patent application to the United States Patent and Trademark Office for its innovative technology.

The invention generally pertains to the field of hydrogels that are capable to capture and contain biological assaults intrusion through the upper airways and eye cavities. Furthermore, the invention details a novel modality for a delivery system for drugs through the nasal mucosa that could get more drug into the body, and resides longer in the nasal cavity.

Recent pre-clinical data by Polyrizon, showed that its product candidate has the potential to reduce the risk of an infection with human coronavirus and may also prevent COVID-19 as well as Influenza Virus H1N1 and may potentially also treat additional Cold viruses. (>>Read Full PR HERE)

Metal Arts Co. Inc. MTRT  – Recap:

Lastly, we placed MTRT on watch in yesterday morning’s premarket report, and got instant results in the form of an enormous single-session push from this OTC play.

The stock traded up from a low of .5778 on the day, and reach a high of 5.05, for a whopping intraday move of 774% which came in on more than 18X the 30-day average volume.

Extended Watchlist:
PSTV, IPHA, SPRT, CHPT, TLSA, GSM, CCAJ, TLSS, TPTW, APTY, RHCO, HBRM